Institutions / BIOS Capital Management, LP
BIOS Capital Management, LP
CIK 1813845 · Institution · as of Dec 31, 2025
Portfolio value
$82.62M
Positions
6
As of
Dec 31, 2025
Top holdings
Dec 31, 2025
| Company | Value | % of portfolio |
|---|---|---|
| Actuate Therapeutics, Inc.ACTU | $61.51M | 74.4% |
| Cognition Therapeutics IncCGTX | $8.10M | 9.8% |
| Opus Genetics, Inc. | $7.40M | 9.0% |
| Lantern Pharma Inc. | $3.06M | 3.7% |
| Rein Therapeutics, Inc. | $1.96M | 2.4% |
| IN8bio, Inc.INAB | $593.0K | 0.7% |
Activity
Dec 31, 2025
InsidersInstitutions
This fund's 13F position changes — what it's buying and selling.No quarter-over-quarter changes yet — position changes appear once we've ingested two consecutive 13F filings for this manager. We currently hold 1 quarter of holdings.